Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer (Q66058988)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer |
clinical trial |
Statements
Efficacy and Safety of a New Leuprolide Acetate 3.75 mg Depot Formulation, GP-Pharm S.A., When Given as Palliative Treatment to Prostate Cancer Patients (English)
0 references
September 2005
0 references
120
0 references
18 year
0 references